Tallahassee Journal

Devirex are now launching lipivir® in UK – a new cold sore gel for people with fever blisters and other symptoms

Devirex are now launching lipivir® in UK – a new cold sore gel for people with fever blisters and other symptoms

Cold sores are one of the world’s most common diseases. Many well-known people suffer from this form of herpes and have blisters and sores regularly. Many different publications have featured pictures of this:

http://www.ranker.com/list/famous-people-with-herpes/celebrity-lists; https://www.pinterest.com/robinatplay/celebs-with-cold-sore/

Or even they all have the same herpes virus (HSV1).

Devirex the Swiss Healthcare company are now launching lipivir® in UK, a new and different cold sore gel which actually prevents cold sores from happening, lipivir® will help millions of people suffering from this condition to a have better life.

Anyone can be hit. In 87% out of 3800 persons who were participants of an investigation in Germany the virus was detected (Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):131-5). Most people have been infected since childhood. These unsightly cold sores can heavily compromise public peoples’ lives as reported in an article in the Independent: http://www.independent.co.uk/voices/columnists/alexa-chung-i-want-my-cold-sore-to-be-discussed-and-sneered-at-on-my-own-terms-1636713.html

Relief is in prospect – from Switzerland!

Around 33% of the population suffer from cold sores and most prefer not to leave home when these unsightly blisters are around their lips.  The Swiss Healthcare company Devirex has developed a new prevention product and this is now available in the UK market. Using it twice daily lipivir® can help radically reduce the frequency of outbreaks. In a survey in Germany 90% of 6‘000 people confirmed this after they had tried it.

Users in UK are writing about their experiences with the product now: http://forum.lipivir.com. Lipivir® is available in UK, CH, A, F at www.lipivir.com

The content in this press release is for information purposes only and should not be considered a substitute for medical advice. As always, you should consult with a qualified healthcare professional before starting or stopping any medication, nutritional supplement or protocols.


Media Contact
Company Name: Devirex
Contact Person: Dr. Paul Scherer (Vice-Chairman)
Email: [email protected]
Phone: +1 (323) 982-7667
Address:Vertriebs AG, Erlenstrasse 4a
City: Rotkreuz
Country: Switzerland
Website: http://www.lipivir.com/


November 2017
« Oct